Mainsail Financial Group’s AbbVie ABBV Stock Holding History

Mainsail Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$312K	Buy	1,240 +115	+10%	+$24.7K	0.11%	65
2026 Q1	$245K	Sell	1,125 -2	-0.2%	-$444	0.1%	60
2025 Q4	$257K	Hold	1,127	–	–	0.11%	60
2025 Q3	$261K	Hold	1,127	–	–	0.11%	57
2025 Q2	$210K	Buy	+1,127	New	+$209K	0.1%	59
2023 Q3	–	Sell	-2,450	Closed	-$330K	–	50
2023 Q2	$330K	Sell	2,450 -119	-5%	-$17.4K	0.31%	43
2023 Q1	$418K	Buy	2,569 +653	+34%	+$99.8K	0.41%	42
2022 Q4	$293K	Buy	+1,916	New	+$294K	0.3%	42

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Mainsail Financial Group's ABBV Position: Q2 2026 in Review

Mainsail Financial Group increased its AbbVie (ABBV) stake by 10% in Q2 2026, buying an estimated $24.7K and bringing the position to 1,240 shares worth $312K. The position accounts for 0.11% of the portfolio, ranked #65.

Mainsail Financial Group first reported a position in ABBV in Q4 2022 and has held it in 8 quarters since. The position peaked at $418K in Q1 2023. 1,316 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Mainsail Financial Group held 1,240 shares of AbbVie worth $312K as of Q2 2026.
Mainsail Financial Group bought 115 AbbVie shares in Q2 2026, an estimated $24.7K.
AbbVie made up 0.11% of Mainsail Financial Group's portfolio in Q2 2026, its #65 holding.
Mainsail Financial Group first reported a position in AbbVie in Q4 2022 and has held it in 8 quarters since.
Mainsail Financial Group's AbbVie position peaked at $418K in Q1 2023.
1,316 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Mainsail Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.